Get caught up! Check out @abc13houston's recent news report on Pulmotect, Inc. here: abc13.com/coronavirus-preven…
#MotivationMonday #Health #clinicalresearch #COVID19
"Scott and his team are hopeful the drug could be used to help frontline workers protect their lungs against the #coronavirus as they treat infected patients. The drug has already passed phase one trials."
#healthcare #COVID19 #HealthcareHeroes #FridayThoughts #Trending
Houston company testing drug to protect against COVID-19 abc13.co/2LdnG24
#FDA approval in hand, we start two Phase-2 clinical trials against #COVID19 this week.
Details here: pulmotect.com/wp-content/upl…
#covid19 #health #trending #science #coronavirus @US_FDA #TuesdayThoughts #news #healthcare
We would like to express our gratitude to all of our doctors, healthcare workers, scientists, and all other essential workers who are working so hard right now to get us through this #coronavirus pandemic.
#COVID19 #CoronaVirusUpdates #StayHomeSaveLives #NationalDoctorDay
@pumotect's PUL-042 has successfully prevented & treated a broad range of respiratory infections in animal models, including those of #coronavirus family members #SARS & #MERS. Learn more about PUL-042 below or visit: pulmotect.com
#COVID19 #CoronaUpdate #health #utmb
@pulmotect is making plans for a phase II clinical trial to test the ability of their immunemodulator PUL-042 in preventing and treating #COVID19. In preclinical studies, PUL-042 has been shown to be effective against other coronaviruses.
#coronavirus #StayHomeSaveLives #houston
Houston researchers test lung inhalant that could protect healthcare workers from COVID-19 bit.ly/2WEOz62
Check out @pulmotect's president, Brenton Scott, as he talks about PUL-042 and the pivot from treating pneumonia in cancer patients to treating pneumonia caused by #COVID19 on @FOX26Houston with @JoseGrinanFOX26
fox26houston.com/video/66530…
#coronavirus #science #flattenthecurve
Update March 23 2020 - Pulmotect's Chairman, Leo Linbeck III, provides an update on plans for a Phase II clinical trial to mitigate impact of #COVID19. Stay tune for updates
#coronavirus #research #Houston #WednesdayThoughts #FlattenTheCurve #Science #healthcare #innovation
Replying to @pulmotect
@pulmotect Chairman & @FanninStudio founder Leo Linbeck III provides an update on Pulmotect’s plans for a Phase II clinical trial to mitigate impact of #COVID19. Learn more: pulmotect.com. #coronavirus #FlattenTheCurve #texas
youtu.be/Tcd52BwIAaw
Pulmotect, Inc. – Bio-pharmaceutical company developing products for severe respiratory diseases ow.ly/KKAB30dZdX7
Mimicking the human lung will provide researchers a unique way to investigate new areas of research for #COPD
ow.ly/l7y750d5j4d
A Flu Pandemic Is Coming, But When, and How Bad Will It Be? #flu govtech.com/em/disaster/A-Fl…
9 takeaways on clinical trials from the patient's view | Clinical Innovation + Technology ow.ly/Hc6p30dZd9v
Meet our experienced management team pulmotect.com/about/manageme…
Our scientific advisory board members include U.S. and european respiratory experts pulmotect.com/about/scientif…
COPD: Changes in the lungs, changes in the microbiome -- ScienceDaily ow.ly/9Pqh30dHagr
How COPD Affects Americans From Coast to Coast #COPD ow.ly/RBsC30dH9K1
Non-Invasive Ventilation Reduces Death from #COPD Breathing Failure | Medpage Today ow.ly/BW5z30dHud8
RT: #PulmonaryHypertension Celebrity Stories: Natalie Cole ow.ly/eOnA30dzJIy
National Initiative Fosters Better Asthma Management | Health & Medical News ow.ly/5fmz30dzE1X








